| Selection bias in trials of transplantation for metastatic breast cancer: have we picked the apple before it was ripe? |
| GP Canellos |
|
JCO Oct 1 1997: 3169–3170.
[PDF]
|
 |
|
Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer |
| |
ZU Rahman, DK Frye, AU Buzdar, TL Smith, L Asmar, RE Champlin, and GN Hortobagyi |
| |
JCO Oct 1 1997: 3171–3177.
[Abstract]
[PDF]
|
|
|
Patient selection in high-dose chemotherapy trials: relevance in high- risk breast cancer |
| |
R Garcia-Carbonero, M Hidalgo, L Paz-Ares, J Calzas, H Gomez, JA Guerra, R Hitt, J Hornedo, R Colomer, and H Cortes-Funes |
| |
JCO Oct 1 1997: 3178–3184.
[Abstract]
[PDF]
|
|
|
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial |
| |
MR Ranson, J Carmichael, K O'Byrne, S Stewart, D Smith, and A Howell |
| |
JCO Oct 1 1997: 3185–3191.
[Abstract]
[PDF]
|
|
|
Breast cancer patients' attitudes about rationing postlumpectomy radiation therapy: applicability of trade-off methods to policy-making |
| |
VA Palda, HA Llewellyn-Thomas, RG Mackenzie, KI Pritchard, and CD Naylor |
| |
JCO Oct 1 1997: 3192–3200.
[Abstract]
[PDF]
|
|
|
Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density |
| |
I Persson, E Thurfjell, and L Holmberg |
| |
JCO Oct 1 1997: 3201–3207.
[Abstract]
[PDF]
|
|
|
Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum |
| |
M De Lena, V Lorusso, C Bottalico, M Brandi, A De Mitrio, A Catino, M Guida, A Latorre, B Leone, C Vallejo, and G Gargano |
| |
JCO Oct 1 1997: 3208–3213.
[Abstract]
[PDF]
|
|
|
Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer |
| |
JA Eastham, MW Kattan, S Groshen, PT Scardino, E Rogers, CE Carlton, Jr, and SP Lerner |
| |
JCO Oct 1 1997: 3214–3222.
[Abstract]
[PDF]
|
|
|
Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin |
| |
CG Leichman, HJ Lenz, L Leichman, K Danenberg, J Baranda, S Groshen, W Boswell, R Metzger, M Tan, and PV Danenberg |
| |
JCO Oct 1 1997: 3223–3229.
[Abstract]
[PDF]
|
|
|
Assessment of genomic damage in colorectal cancer by DNA fingerprinting: prognostic applications |
| |
R Arribas, G Capella, S Tortola, L Masramon, WE Grizzle, M Perucho, and MA Peinado |
| |
JCO Oct 1 1997: 3230–3240.
[Abstract]
[PDF]
|
|
|
Conservative treatment of rectal adenocarcinoma with endocavitary irradiation or wide local excision and postoperative irradiation |
| |
WM Mendenhall, WR Rout, JN Vauthey, LS Haigh, RA Zlotecki, and EM Copeland, 3rd |
| |
JCO Oct 1 1997: 3241–3248.
[Abstract]
[PDF]
|
|
|
Evaluation of newer prognostic markers for adult soft tissue sarcomas |
| |
EA Levine, T Holzmayer, S Bacus, E Mechetner, R Mera, C Bolliger, IB Roninson, and TK Das Gupta |
| |
JCO Oct 1 1997: 3249–3257.
[Abstract]
[PDF]
|
|
|
High-dose cyclophosphamide for poor-prognosis and recurrent pediatric brain tumors: a dose-escalation study |
| |
SM Yule, NK Foreman, C Mitchell, N Gouldon, P May, and HP McDowell |
| |
JCO Oct 1 1997: 3258–3265.
[Abstract]
[PDF]
|
|
|
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma |
| |
DG Maloney, AJ Grillo-Lopez, DJ Bodkin, CA White, TM Liles, I Royston, C Varns, J Rosenberg, and R Levy |
| |
JCO Oct 1 1997: 3266–3274.
[Abstract]
[PDF]
|
|
|
Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group B |
| |
DR Budman, GR Petroni, JL Johnson, MR Cooper, DM Schlossman, M Barcos, and BA Peterson |
| |
JCO Oct 1 1997: 3275–3279.
[Abstract]
[PDF]
|
|
| Karnofsky Memorial Lecture. Hereditary cancer: theme and variations |
| AG Knudson |
|
JCO Oct 1 1997: 3280–3287.
[PDF]
|
|
| 1997 update of recommendations for the use of hematopoietic colony- stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology |
|
|
JCO Oct 1 1997: 3288.
[PDF]
|
|
| Reed-Sternberg cells in spinal fluid |
| W Caceres, L Delgado, and JR Sanchez |
|
JCO Oct 1 1997: 3289–3290.
[PDF]
|
|
| Hypofractionation, not rapid-fractionation |
| CR Thomas, Jr, S Milito, and AT Turrisi, 3rd |
|
JCO Oct 1 1997: 3291–3293.
[PDF]
|
|
| Delayed administration of dexrazoxane provides cardioprotection against anthracyclines in breast cancer or acute myeloid leukemia |
| P Lemez |
|
JCO Oct 1 1997: 3293–3295.
[PDF]
|
|
